ZA863873B - Morphinane derivatives - Google Patents

Morphinane derivatives

Info

Publication number
ZA863873B
ZA863873B ZA863873A ZA863873A ZA863873B ZA 863873 B ZA863873 B ZA 863873B ZA 863873 A ZA863873 A ZA 863873A ZA 863873 A ZA863873 A ZA 863873A ZA 863873 B ZA863873 B ZA 863873B
Authority
ZA
South Africa
Prior art keywords
morphinane derivatives
morphinane
derivatives
Prior art date
Application number
ZA863873A
Other languages
English (en)
Inventor
Laszlo Revesz
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA863873B publication Critical patent/ZA863873B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA863873A 1985-05-23 1986-05-23 Morphinane derivatives ZA863873B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3518525 1985-05-23

Publications (1)

Publication Number Publication Date
ZA863873B true ZA863873B (en) 1988-01-27

Family

ID=6271435

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA863873A ZA863873B (en) 1985-05-23 1986-05-23 Morphinane derivatives

Country Status (18)

Country Link
JP (1) JPS61271275A (fr)
AU (1) AU594954B2 (fr)
BE (1) BE904796A (fr)
DK (1) DK240386A (fr)
ES (1) ES8802318A1 (fr)
FI (1) FI862124A (fr)
FR (1) FR2582309B1 (fr)
GB (1) GB2175898B (fr)
GR (1) GR861318B (fr)
HU (1) HU196376B (fr)
IL (1) IL78872A0 (fr)
IT (1) IT1203791B (fr)
LU (1) LU86435A1 (fr)
NL (1) NL8601188A (fr)
NZ (1) NZ216250A (fr)
PH (1) PH23341A (fr)
SE (1) SE8602308L (fr)
ZA (1) ZA863873B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
JP2525552B2 (ja) 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
EP0661283B1 (fr) * 1993-07-19 1998-10-21 Toray Industries, Inc. Agent de protection de cellules cerebrales
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
AR005423A1 (es) 1996-01-10 1999-06-23 Smithkline Beecham Spa Derivados morfinoides condensados con heterociclos (ii), su uso como sustancia terapeutica y para preparar medicamentos, composiciones farmaceuticasque los contienen y procedimiento para preparar dichos derivados.
EP1312361A1 (fr) * 1996-11-25 2003-05-21 Toray Industries, Inc. Agent antiprurigineux
AU6117298A (en) * 1997-07-25 1999-02-16 Toray Industries, Inc. Hyponatremia remedies
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
WO2003097608A2 (fr) 2002-05-17 2003-11-27 Jenken Biosciences, Inc. Composes opioides et de type opioide et leurs utilisations
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP4957489B2 (ja) * 2002-10-09 2012-06-20 東レ株式会社 含窒素環状置換基を有するモルヒナン誘導体またはその薬理学的に許容される酸付加塩を含有する医薬
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
AU2009214500B2 (en) * 2008-02-14 2014-10-23 Alkermes, Inc. Selective opioid compounds
US8980906B2 (en) * 2012-12-14 2015-03-17 Purdue Pharma L.P. Pyridonemorphinan analogs and biological activity on opioid receptors
JP6141444B2 (ja) * 2012-12-14 2017-06-07 パーデュー、ファーマ、リミテッド、パートナーシップ スピロ環式モルフィナンおよびこれらの使用
AR096851A1 (es) * 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
WO2015192053A1 (fr) * 2014-06-13 2015-12-17 Purdue Pharma L.P. Dérivés d'azamophinan et leur utilisation

Also Published As

Publication number Publication date
IT8648050A0 (it) 1986-05-23
GB8612159D0 (en) 1986-06-25
IL78872A0 (en) 1986-09-30
LU86435A1 (fr) 1986-12-05
HU196376B (en) 1988-11-28
JPS61271275A (ja) 1986-12-01
HUT41737A (en) 1987-05-28
FR2582309B1 (fr) 1989-08-18
GB2175898B (en) 1989-07-05
SE8602308D0 (sv) 1986-05-21
DK240386A (da) 1986-11-24
PH23341A (en) 1989-07-14
SE8602308L (sv) 1986-11-24
AU594954B2 (en) 1990-03-22
FI862124A (fi) 1986-11-24
GB2175898A (en) 1986-12-10
FR2582309A1 (fr) 1986-11-28
NL8601188A (nl) 1986-12-16
ES8802318A1 (es) 1988-05-01
FI862124A0 (fi) 1986-05-21
AU5763786A (en) 1986-11-27
ES555200A0 (es) 1988-05-01
BE904796A (fr) 1986-11-21
GR861318B (en) 1986-09-19
IT1203791B (it) 1989-02-23
NZ216250A (en) 1990-04-26
DK240386D0 (da) 1986-05-22

Similar Documents

Publication Publication Date Title
EP0191562A3 (en) Tetrahydrocarbazolone derivatives
GB8612159D0 (en) Morphinane derivatives
GB8620638D0 (en) Derivatives
GB8617292D0 (en) Poly-4-aminopyyrrole-2-carboxamido derivatives
GB8601292D0 (en) 13beta-alkylmilbemycin derivatives
GB8627491D0 (en) 5-phenyl-2-oxazole derivatives
GB2176181B (en) Aryltetralin derivatives
GB8614176D0 (en) Piperonylcarboxamido derivatives
GB2172286B (en) Tetraprenylamine derivatives
GB2174703B (en) Pyridinylpiperazine derivatives
GB2177692B (en) Diazinylpiperidine derivatives
GB8623513D0 (en) Glucosylmoranoline derivatives
GB8520631D0 (en) Derivatives
GB8623075D0 (en) Bicyclocatechol derivatives
GB8511892D0 (en) Fluoralkane derivatives
GB2177695B (en) Aminoalkylamide derivatives
GB8600575D0 (en) Benzonorbornene derivatives
GB2177090B (en) 10-alpha-methoxy-6-methyl-ergoline derivatives
GB2174092B (en) Eburnamenine derivatives
GB8630780D0 (en) Estradiene derivatives
GB8630781D0 (en) Estrene derivatives
GB8508422D0 (en) Punaglandin derivatives
GB8527320D0 (en) Flavolignan derivatives
GB8609591D0 (en) Pyridazodiazepine derivatives
GB8501656D0 (en) D-nor-7-ergoline derivatives